Schroder Investment Management Group
TRIB

Schroder Investment Management Group’s Trinity Biotech TRIB Stock Holding History

Schroder Investment Management Group’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-3,311
Closed -$6.57M – 1190
2016
Q3 		$6.57M Hold
3,311
– – 0.01% 692
2016
Q2 		$5.63M Hold
3,311
– – 0.01% 709
2016
Q1 		$5.71M Hold
3,311
– – 0.01% 674
2015
Q4 		$5.84M Buy
3,311
+291
+10% +$515K 0.01% 716
2015
Q3 		$5.18M Buy
3,020
+4
+0.1% +$9.65K 0.01% 739
2015
Q2 		$8.15M Sell
3,016
-45
-1% -$117K 0.02% 677
2015
Q1 		$8.64M Sell
3,061
-54
-2% -$150K 0.02% 676
2014
Q4 		$8.18M Hold
3,115
– – 0.02% 689
2014
Q3 		$8.54M Buy
3,115
+70
+2% +$227K 0.01% 698
2014
Q2 		$10.5M Buy
3,045
+1,548
+103% +$5.5M 0.01% 622
2014
Q1 		$5.44M Buy
+1,497
New +$5.89M 0.01% 756

Other funds holding TRIB

PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $486M AUM 50.29% 1-Year Est. Return
SCM
Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return
2L
22NW LP Seattle, Washington $105M AUM 38.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

Schroder Investment Management Group's TRIB Position: Q4 2016 in Review

Schroder Investment Management Group sold out of Trinity Biotech (TRIB) in Q4 2016, closing a stake of 3,311 shares — an estimated $6.57M sold.

Schroder Investment Management Group first reported a position in TRIB in Q1 2014 and held it in 11 quarters. The position peaked at $10.5M in Q2 2014. 71 funds tracked by Wall St. Rank hold TRIB as of Q4 2016.

  • Schroder Investment Management Group reported no remaining Trinity Biotech position as of Q4 2016 after selling out during the quarter.
  • Schroder Investment Management Group sold 3,311 Trinity Biotech shares in Q4 2016, an estimated $6.57M.
  • Schroder Investment Management Group first reported a position in Trinity Biotech in Q1 2014 and held it in 11 quarters.
  • Schroder Investment Management Group's Trinity Biotech position peaked at $10.5M in Q2 2014.
  • 71 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2016.

Based on Schroder Investment Management Group's 13F filing for Q4 2016, filed 10 Feb 2017.